1st Jul 2008 07:00
Ultrasis plc
Ultrasis plc appoints JBP to head up financial,
corporate and consumer communications
Ultrasis plc, the provider of computer-delivered, interactive healthcare products and associated services, has appointed JBP to lead its financial PR, investor relations and corporate, trade and consumer communications.
The appointment is made as AIM-listed Ultrasis embarks on a major rollout of its flagship product designed to treat anxiety and depression, Beating the Blues, to a wider retail audience.
Beating the Blues is an eight-week, web-based treatment programme for depression based on Cognitive Behavioural Therapy (CBT) which, following rigorous assessment was approved by NICE (National Institute for Health and Clinical Excellence) for use in the NHS in February 2006.
Nigel Brabbins, Chief Executive of Ultrasis plc said: "We want our potential investors, analysts, employees, customers and the media to be kept fully abreast of some fast moving developments, which is why JBP has come on board to lead a wider strategic communications programme, targeting both existing customers and new, private ones."
JBP was established 24 years ago and has extensive experience developing communications strategies for companies operating in the healthcare sector and manages national and international clients.
Financial communications will be handled by the company's investor relations division, Performance Communications.
Ends
For further information please contact:
Ultrasis plc
Nigel Brabbins, Chief Executive
+44 (0) 20 7566 3900
Geoff Nash,
FinnCap
Nominated Advisor and Joint Broker
+44 (0) 207600 1658
John Webb,
Marshall Securities
Joint Broker
+44 (0) 207 490 3788
Media Enquiries
JBP
Karen White/Sarah Rice
+44 (0) 117 9073400
[email protected] ; [email protected]
Related Shares:
Ultrasis Plc